Evofem Biosciences Inc
(OTCQB:EVFM)
$0.0479
-0.0002[-0.42%]
At close: Feb 8
$0.0653
0.0174[36.33%]
After Hours: 4:00PM EDT
Day Range0.047 - 0.05052 Wk Range0.041 - 1.570Open / Close0.048 / 0.048Float / Outstanding121.036M / 121.223M
Vol / Avg.1.725M / 1.976MMkt Cap5.807MP/E-50d Avg. Price0.070
Div / Yield (Forward)- / -%Payout Ratio-Total Float121.036MEPS-6.260

Evofem Biosciences Stock (OTC:EVFM), Quotes and News Summary

Evofem Biosciences Stock (OTC: EVFM) stock price, news, charts, stock research, profile.

Loading...
Day Range0.047 - 0.05052 Wk Range0.041 - 1.570Open / Close0.048 / 0.048Float / Outstanding121.036M / 121.223M
Vol / Avg.1.725M / 1.976MMkt Cap5.807MP/E-50d Avg. Price0.070
Div / Yield (Forward)- / -%Payout Ratio-Total Float121.036MEPS-6.260
PRNewswire - Oct 3, 2022, 8:30AM
PRNewswire - Sep 16, 2022, 6:00AM
Seeking Alpha - Sep 12, 2022, 11:08AM
Seeking Alpha - Aug 4, 2022, 4:37PM
Seeking Alpha - Jul 13, 2022, 10:57AM
Seeking Alpha - Jul 7, 2022, 1:42PM
Seeking Alpha - Jul 6, 2022, 1:48PM
InvestorPlace - Jun 28, 2022, 4:58PM
Seeking Alpha - May 20, 2022, 6:59AM
Seeking Alpha - May 19, 2022, 6:05PM
Sector: Health Care.Industry: Pharmaceuticals
Evofem Biosciences Inc is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmitted infections (STIs). The company's product, Phexxi (lactic acid, citric acid and potassium bitartrate), is a hormone-free, prescription vaginal gel approved in the United States for the prevention of pregnancy. The company is also evaluating its investigational drug candidate EVO100 vaginal gel for the prevention of urogenital transmission of Chlamydia trachomatis infection (chlamydia) and Neisseria gonorrhoeae infection (gonorrhea) in women.

Earnings

see more
Q1 2023Est.ActualSurprise
EPS
(EXPECTED)2023-05-03
REV
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-03-02
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Evofem Biosciences (EVFM) stock?

A

You can purchase shares of Evofem Biosciences (OTCQB: EVFM) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Evofem Biosciences's (EVFM) competitors?

A

There are no as such competitors for Evofem Biosciences.

Q

What is the target price for Evofem Biosciences (EVFM) stock?

A

The latest price target for Evofem Biosciences (OTCQB: EVFM) was reported by Stifel on Thursday, October 13, 2022. The analyst firm set a price target for 0.50 expecting EVFM to rise to within 12 months (a possible 943.84% upside). 9 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Evofem Biosciences (EVFM)?

A

The stock price for Evofem Biosciences (OTCQB: EVFM) is $0.0479 last updated February 8, 2023 at 8:54 PM UTC.

Q

Does Evofem Biosciences (EVFM) pay a dividend?

A

There are no upcoming dividends for Evofem Biosciences.

Q

When is Evofem Biosciences (OTCQB:EVFM) reporting earnings?

A

Evofem Biosciences’s Q1 earnings are confirmed for Wednesday, May 3, 2023.

Q

Is Evofem Biosciences (EVFM) going to split?

A

There is no upcoming split for Evofem Biosciences.

Q

What sector and industry does Evofem Biosciences (EVFM) operate in?

A

Evofem Biosciences is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCQB.

Evofem Biosciences Stock (OTC:EVFM), Quotes and News Summary

Evofem Biosciences Stock (OTC: EVFM) stock price, news, charts, stock research, profile.

Loading...
Day Range0.047 - 0.05052 Wk Range0.041 - 1.570Open / Close0.048 / 0.048Float / Outstanding121.036M / 121.223M
Vol / Avg.1.725M / 1.976MMkt Cap5.807MP/E-50d Avg. Price0.070
Div / Yield (Forward)- / -%Payout Ratio-Total Float121.036MEPS-6.260
PRNewswire - Oct 3, 2022, 8:30AM
PRNewswire - Sep 16, 2022, 6:00AM
Seeking Alpha - Sep 12, 2022, 11:08AM
Seeking Alpha - Aug 4, 2022, 4:37PM
Seeking Alpha - Jul 13, 2022, 10:57AM
Seeking Alpha - Jul 7, 2022, 1:42PM
Seeking Alpha - Jul 6, 2022, 1:48PM
InvestorPlace - Jun 28, 2022, 4:58PM
Seeking Alpha - May 20, 2022, 6:59AM
Seeking Alpha - May 19, 2022, 6:05PM
Sector: Health Care.Industry: Pharmaceuticals
Evofem Biosciences Inc is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmitted infections (STIs). The company's product, Phexxi (lactic acid, citric acid and potassium bitartrate), is a hormone-free, prescription vaginal gel approved in the United States for the prevention of pregnancy. The company is also evaluating its investigational drug candidate EVO100 vaginal gel for the prevention of urogenital transmission of Chlamydia trachomatis infection (chlamydia) and Neisseria gonorrhoeae infection (gonorrhea) in women.

Earnings

see more
Q1 2023Est.ActualSurprise
EPS
(EXPECTED)2023-05-03
REV
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-03-02
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Evofem Biosciences (EVFM) stock?

A

You can purchase shares of Evofem Biosciences (OTCQB: EVFM) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Evofem Biosciences's (EVFM) competitors?

A

There are no as such competitors for Evofem Biosciences.

Q

What is the target price for Evofem Biosciences (EVFM) stock?

A

The latest price target for Evofem Biosciences (OTCQB: EVFM) was reported by Stifel on Thursday, October 13, 2022. The analyst firm set a price target for 0.50 expecting EVFM to rise to within 12 months (a possible 943.84% upside). 9 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Evofem Biosciences (EVFM)?

A

The stock price for Evofem Biosciences (OTCQB: EVFM) is $0.0479 last updated February 8, 2023 at 8:54 PM UTC.

Q

Does Evofem Biosciences (EVFM) pay a dividend?

A

There are no upcoming dividends for Evofem Biosciences.

Q

When is Evofem Biosciences (OTCQB:EVFM) reporting earnings?

A

Evofem Biosciences’s Q1 earnings are confirmed for Wednesday, May 3, 2023.

Q

Is Evofem Biosciences (EVFM) going to split?

A

There is no upcoming split for Evofem Biosciences.

Q

What sector and industry does Evofem Biosciences (EVFM) operate in?

A

Evofem Biosciences is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCQB.

Evofem Biosciences Stock (OTC:EVFM), Quotes and News Summary

Evofem Biosciences Stock (OTC: EVFM) stock price, news, charts, stock research, profile.

Loading...
Day Range0.047 - 0.05052 Wk Range0.041 - 1.570Open / Close0.048 / 0.048Float / Outstanding121.036M / 121.223M
Vol / Avg.1.725M / 1.976MMkt Cap5.807MP/E-50d Avg. Price0.070
Div / Yield (Forward)- / -%Payout Ratio-Total Float121.036MEPS-6.260
PRNewswire - Oct 3, 2022, 8:30AM
PRNewswire - Sep 16, 2022, 6:00AM
Seeking Alpha - Sep 12, 2022, 11:08AM
Seeking Alpha - Aug 4, 2022, 4:37PM
Seeking Alpha - Jul 13, 2022, 10:57AM
Seeking Alpha - Jul 7, 2022, 1:42PM
Seeking Alpha - Jul 6, 2022, 1:48PM
InvestorPlace - Jun 28, 2022, 4:58PM
Seeking Alpha - May 20, 2022, 6:59AM
Seeking Alpha - May 19, 2022, 6:05PM
Sector: Health Care.Industry: Pharmaceuticals
Evofem Biosciences Inc is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmitted infections (STIs). The company's product, Phexxi (lactic acid, citric acid and potassium bitartrate), is a hormone-free, prescription vaginal gel approved in the United States for the prevention of pregnancy. The company is also evaluating its investigational drug candidate EVO100 vaginal gel for the prevention of urogenital transmission of Chlamydia trachomatis infection (chlamydia) and Neisseria gonorrhoeae infection (gonorrhea) in women.

Earnings

see more
Q1 2023Est.ActualSurprise
EPS
(EXPECTED)2023-05-03
REV
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-03-02
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Evofem Biosciences (EVFM) stock?

A

You can purchase shares of Evofem Biosciences (OTCQB: EVFM) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Evofem Biosciences's (EVFM) competitors?

A

There are no as such competitors for Evofem Biosciences.

Q

What is the target price for Evofem Biosciences (EVFM) stock?

A

The latest price target for Evofem Biosciences (OTCQB: EVFM) was reported by Stifel on Thursday, October 13, 2022. The analyst firm set a price target for 0.50 expecting EVFM to rise to within 12 months (a possible 943.84% upside). 9 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Evofem Biosciences (EVFM)?

A

The stock price for Evofem Biosciences (OTCQB: EVFM) is $0.0479 last updated February 8, 2023 at 8:54 PM UTC.

Q

Does Evofem Biosciences (EVFM) pay a dividend?

A

There are no upcoming dividends for Evofem Biosciences.

Q

When is Evofem Biosciences (OTCQB:EVFM) reporting earnings?

A

Evofem Biosciences’s Q1 earnings are confirmed for Wednesday, May 3, 2023.

Q

Is Evofem Biosciences (EVFM) going to split?

A

There is no upcoming split for Evofem Biosciences.

Q

What sector and industry does Evofem Biosciences (EVFM) operate in?

A

Evofem Biosciences is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCQB.

Evofem Biosciences Stock (OTC:EVFM), Quotes and News Summary

Evofem Biosciences Stock (OTC: EVFM) stock price, news, charts, stock research, profile.

Loading...
Day Range0.047 - 0.05052 Wk Range0.041 - 1.570Open / Close0.048 / 0.048Float / Outstanding121.036M / 121.223M
Vol / Avg.1.725M / 1.976MMkt Cap5.807MP/E-50d Avg. Price0.070
Div / Yield (Forward)- / -%Payout Ratio-Total Float121.036MEPS-6.260
PRNewswire - Oct 3, 2022, 8:30AM
PRNewswire - Sep 16, 2022, 6:00AM
Seeking Alpha - Sep 12, 2022, 11:08AM
Seeking Alpha - Aug 4, 2022, 4:37PM
Seeking Alpha - Jul 13, 2022, 10:57AM
Seeking Alpha - Jul 7, 2022, 1:42PM
Seeking Alpha - Jul 6, 2022, 1:48PM
InvestorPlace - Jun 28, 2022, 4:58PM
Seeking Alpha - May 20, 2022, 6:59AM
Seeking Alpha - May 19, 2022, 6:05PM
Sector: Health Care.Industry: Pharmaceuticals
Evofem Biosciences Inc is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmitted infections (STIs). The company's product, Phexxi (lactic acid, citric acid and potassium bitartrate), is a hormone-free, prescription vaginal gel approved in the United States for the prevention of pregnancy. The company is also evaluating its investigational drug candidate EVO100 vaginal gel for the prevention of urogenital transmission of Chlamydia trachomatis infection (chlamydia) and Neisseria gonorrhoeae infection (gonorrhea) in women.

Earnings

see more
Q1 2023Est.ActualSurprise
EPS
(EXPECTED)2023-05-03
REV
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-03-02
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Evofem Biosciences (EVFM) stock?

A

You can purchase shares of Evofem Biosciences (OTCQB: EVFM) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Evofem Biosciences's (EVFM) competitors?

A

There are no as such competitors for Evofem Biosciences.

Q

What is the target price for Evofem Biosciences (EVFM) stock?

A

The latest price target for Evofem Biosciences (OTCQB: EVFM) was reported by Stifel on Thursday, October 13, 2022. The analyst firm set a price target for 0.50 expecting EVFM to rise to within 12 months (a possible 943.84% upside). 9 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Evofem Biosciences (EVFM)?

A

The stock price for Evofem Biosciences (OTCQB: EVFM) is $0.0479 last updated February 8, 2023 at 8:54 PM UTC.

Q

Does Evofem Biosciences (EVFM) pay a dividend?

A

There are no upcoming dividends for Evofem Biosciences.

Q

When is Evofem Biosciences (OTCQB:EVFM) reporting earnings?

A

Evofem Biosciences’s Q1 earnings are confirmed for Wednesday, May 3, 2023.

Q

Is Evofem Biosciences (EVFM) going to split?

A

There is no upcoming split for Evofem Biosciences.

Q

What sector and industry does Evofem Biosciences (EVFM) operate in?

A

Evofem Biosciences is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCQB.

Evofem Biosciences Stock (OTC:EVFM), Quotes and News Summary

Evofem Biosciences Stock (OTC: EVFM) stock price, news, charts, stock research, profile.

Loading...
Day Range0.047 - 0.05052 Wk Range0.041 - 1.570Open / Close0.048 / 0.048Float / Outstanding121.036M / 121.223M
Vol / Avg.1.725M / 1.976MMkt Cap5.807MP/E-50d Avg. Price0.070
Div / Yield (Forward)- / -%Payout Ratio-Total Float121.036MEPS-6.260
PRNewswire - Oct 3, 2022, 8:30AM
PRNewswire - Sep 16, 2022, 6:00AM
Seeking Alpha - Sep 12, 2022, 11:08AM
Seeking Alpha - Aug 4, 2022, 4:37PM
Seeking Alpha - Jul 13, 2022, 10:57AM
Seeking Alpha - Jul 7, 2022, 1:42PM
Seeking Alpha - Jul 6, 2022, 1:48PM
InvestorPlace - Jun 28, 2022, 4:58PM
Seeking Alpha - May 20, 2022, 6:59AM
Seeking Alpha - May 19, 2022, 6:05PM
Sector: Health Care.Industry: Pharmaceuticals
Evofem Biosciences Inc is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmitted infections (STIs). The company's product, Phexxi (lactic acid, citric acid and potassium bitartrate), is a hormone-free, prescription vaginal gel approved in the United States for the prevention of pregnancy. The company is also evaluating its investigational drug candidate EVO100 vaginal gel for the prevention of urogenital transmission of Chlamydia trachomatis infection (chlamydia) and Neisseria gonorrhoeae infection (gonorrhea) in women.

Earnings

see more
Q1 2023Est.ActualSurprise
EPS
(EXPECTED)2023-05-03
REV
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-03-02
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Evofem Biosciences (EVFM) stock?

A

You can purchase shares of Evofem Biosciences (OTCQB: EVFM) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Evofem Biosciences's (EVFM) competitors?

A

There are no as such competitors for Evofem Biosciences.

Q

What is the target price for Evofem Biosciences (EVFM) stock?

A

The latest price target for Evofem Biosciences (OTCQB: EVFM) was reported by Stifel on Thursday, October 13, 2022. The analyst firm set a price target for 0.50 expecting EVFM to rise to within 12 months (a possible 943.84% upside). 9 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Evofem Biosciences (EVFM)?

A

The stock price for Evofem Biosciences (OTCQB: EVFM) is $0.0479 last updated February 8, 2023 at 8:54 PM UTC.

Q

Does Evofem Biosciences (EVFM) pay a dividend?

A

There are no upcoming dividends for Evofem Biosciences.

Q

When is Evofem Biosciences (OTCQB:EVFM) reporting earnings?

A

Evofem Biosciences’s Q1 earnings are confirmed for Wednesday, May 3, 2023.

Q

Is Evofem Biosciences (EVFM) going to split?

A

There is no upcoming split for Evofem Biosciences.

Q

What sector and industry does Evofem Biosciences (EVFM) operate in?

A

Evofem Biosciences is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCQB.

Evofem Biosciences Stock (OTC:EVFM), Quotes and News Summary

Evofem Biosciences Stock (OTC: EVFM) stock price, news, charts, stock research, profile.

Loading...
Day Range0.047 - 0.05052 Wk Range0.041 - 1.570Open / Close0.048 / 0.048Float / Outstanding121.036M / 121.223M
Vol / Avg.1.725M / 1.976MMkt Cap5.807MP/E-50d Avg. Price0.070
Div / Yield (Forward)- / -%Payout Ratio-Total Float121.036MEPS-6.260
PRNewswire - Oct 3, 2022, 8:30AM
PRNewswire - Sep 16, 2022, 6:00AM
Seeking Alpha - Sep 12, 2022, 11:08AM
Seeking Alpha - Aug 4, 2022, 4:37PM
Seeking Alpha - Jul 13, 2022, 10:57AM
Seeking Alpha - Jul 7, 2022, 1:42PM
Seeking Alpha - Jul 6, 2022, 1:48PM
InvestorPlace - Jun 28, 2022, 4:58PM
Seeking Alpha - May 20, 2022, 6:59AM
Seeking Alpha - May 19, 2022, 6:05PM
Sector: Health Care.Industry: Pharmaceuticals
Evofem Biosciences Inc is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmitted infections (STIs). The company's product, Phexxi (lactic acid, citric acid and potassium bitartrate), is a hormone-free, prescription vaginal gel approved in the United States for the prevention of pregnancy. The company is also evaluating its investigational drug candidate EVO100 vaginal gel for the prevention of urogenital transmission of Chlamydia trachomatis infection (chlamydia) and Neisseria gonorrhoeae infection (gonorrhea) in women.

Earnings

see more
Q1 2023Est.ActualSurprise
EPS
(EXPECTED)2023-05-03
REV
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-03-02
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Evofem Biosciences (EVFM) stock?

A

You can purchase shares of Evofem Biosciences (OTCQB: EVFM) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Evofem Biosciences's (EVFM) competitors?

A

There are no as such competitors for Evofem Biosciences.

Q

What is the target price for Evofem Biosciences (EVFM) stock?

A

The latest price target for Evofem Biosciences (OTCQB: EVFM) was reported by Stifel on Thursday, October 13, 2022. The analyst firm set a price target for 0.50 expecting EVFM to rise to within 12 months (a possible 943.84% upside). 9 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Evofem Biosciences (EVFM)?

A

The stock price for Evofem Biosciences (OTCQB: EVFM) is $0.0479 last updated February 8, 2023 at 8:54 PM UTC.

Q

Does Evofem Biosciences (EVFM) pay a dividend?

A

There are no upcoming dividends for Evofem Biosciences.

Q

When is Evofem Biosciences (OTCQB:EVFM) reporting earnings?

A

Evofem Biosciences’s Q1 earnings are confirmed for Wednesday, May 3, 2023.

Q

Is Evofem Biosciences (EVFM) going to split?

A

There is no upcoming split for Evofem Biosciences.

Q

What sector and industry does Evofem Biosciences (EVFM) operate in?

A

Evofem Biosciences is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCQB.

Evofem Biosciences Stock (OTC:EVFM), Quotes and News Summary

Evofem Biosciences Stock (OTC: EVFM) stock price, news, charts, stock research, profile.

Loading...
Day Range0.047 - 0.05052 Wk Range0.041 - 1.570Open / Close0.048 / 0.048Float / Outstanding121.036M / 121.223M
Vol / Avg.1.725M / 1.976MMkt Cap5.807MP/E-50d Avg. Price0.070
Div / Yield (Forward)- / -%Payout Ratio-Total Float121.036MEPS-6.260
PRNewswire - Oct 3, 2022, 8:30AM
PRNewswire - Sep 16, 2022, 6:00AM
Seeking Alpha - Sep 12, 2022, 11:08AM
Seeking Alpha - Aug 4, 2022, 4:37PM
Seeking Alpha - Jul 13, 2022, 10:57AM
Seeking Alpha - Jul 7, 2022, 1:42PM
Seeking Alpha - Jul 6, 2022, 1:48PM
InvestorPlace - Jun 28, 2022, 4:58PM
Seeking Alpha - May 20, 2022, 6:59AM
Seeking Alpha - May 19, 2022, 6:05PM
Sector: Health Care.Industry: Pharmaceuticals
Evofem Biosciences Inc is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmitted infections (STIs). The company's product, Phexxi (lactic acid, citric acid and potassium bitartrate), is a hormone-free, prescription vaginal gel approved in the United States for the prevention of pregnancy. The company is also evaluating its investigational drug candidate EVO100 vaginal gel for the prevention of urogenital transmission of Chlamydia trachomatis infection (chlamydia) and Neisseria gonorrhoeae infection (gonorrhea) in women.

Earnings

see more
Q1 2023Est.ActualSurprise
EPS
(EXPECTED)2023-05-03
REV
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-03-02
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Evofem Biosciences (EVFM) stock?

A

You can purchase shares of Evofem Biosciences (OTCQB: EVFM) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Evofem Biosciences's (EVFM) competitors?

A

There are no as such competitors for Evofem Biosciences.

Q

What is the target price for Evofem Biosciences (EVFM) stock?

A

The latest price target for Evofem Biosciences (OTCQB: EVFM) was reported by Stifel on Thursday, October 13, 2022. The analyst firm set a price target for 0.50 expecting EVFM to rise to within 12 months (a possible 943.84% upside). 9 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Evofem Biosciences (EVFM)?

A

The stock price for Evofem Biosciences (OTCQB: EVFM) is $0.0479 last updated February 8, 2023 at 8:54 PM UTC.

Q

Does Evofem Biosciences (EVFM) pay a dividend?

A

There are no upcoming dividends for Evofem Biosciences.

Q

When is Evofem Biosciences (OTCQB:EVFM) reporting earnings?

A

Evofem Biosciences’s Q1 earnings are confirmed for Wednesday, May 3, 2023.

Q

Is Evofem Biosciences (EVFM) going to split?

A

There is no upcoming split for Evofem Biosciences.

Q

What sector and industry does Evofem Biosciences (EVFM) operate in?

A

Evofem Biosciences is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCQB.

Evofem Biosciences Stock (OTC:EVFM), Quotes and News Summary

Evofem Biosciences Stock (OTC: EVFM) stock price, news, charts, stock research, profile.

Loading...
Day Range0.047 - 0.05052 Wk Range0.041 - 1.570Open / Close0.048 / 0.048Float / Outstanding121.036M / 121.223M
Vol / Avg.1.725M / 1.976MMkt Cap5.807MP/E-50d Avg. Price0.070
Div / Yield (Forward)- / -%Payout Ratio-Total Float121.036MEPS-6.260
PRNewswire - Oct 3, 2022, 8:30AM
PRNewswire - Sep 16, 2022, 6:00AM
Seeking Alpha - Sep 12, 2022, 11:08AM
Seeking Alpha - Aug 4, 2022, 4:37PM
Seeking Alpha - Jul 13, 2022, 10:57AM
Seeking Alpha - Jul 7, 2022, 1:42PM
Seeking Alpha - Jul 6, 2022, 1:48PM
InvestorPlace - Jun 28, 2022, 4:58PM
Seeking Alpha - May 20, 2022, 6:59AM
Seeking Alpha - May 19, 2022, 6:05PM
Sector: Health Care.Industry: Pharmaceuticals
Evofem Biosciences Inc is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmitted infections (STIs). The company's product, Phexxi (lactic acid, citric acid and potassium bitartrate), is a hormone-free, prescription vaginal gel approved in the United States for the prevention of pregnancy. The company is also evaluating its investigational drug candidate EVO100 vaginal gel for the prevention of urogenital transmission of Chlamydia trachomatis infection (chlamydia) and Neisseria gonorrhoeae infection (gonorrhea) in women.

Earnings

see more
Q1 2023Est.ActualSurprise
EPS
(EXPECTED)2023-05-03
REV
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-03-02
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Evofem Biosciences (EVFM) stock?

A

You can purchase shares of Evofem Biosciences (OTCQB: EVFM) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Evofem Biosciences's (EVFM) competitors?

A

There are no as such competitors for Evofem Biosciences.

Q

What is the target price for Evofem Biosciences (EVFM) stock?

A

The latest price target for Evofem Biosciences (OTCQB: EVFM) was reported by Stifel on Thursday, October 13, 2022. The analyst firm set a price target for 0.50 expecting EVFM to rise to within 12 months (a possible 943.84% upside). 9 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Evofem Biosciences (EVFM)?

A

The stock price for Evofem Biosciences (OTCQB: EVFM) is $0.0479 last updated February 8, 2023 at 8:54 PM UTC.

Q

Does Evofem Biosciences (EVFM) pay a dividend?

A

There are no upcoming dividends for Evofem Biosciences.

Q

When is Evofem Biosciences (OTCQB:EVFM) reporting earnings?

A

Evofem Biosciences’s Q1 earnings are confirmed for Wednesday, May 3, 2023.

Q

Is Evofem Biosciences (EVFM) going to split?

A

There is no upcoming split for Evofem Biosciences.

Q

What sector and industry does Evofem Biosciences (EVFM) operate in?

A

Evofem Biosciences is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCQB.

Evofem Biosciences Stock (OTC:EVFM), Quotes and News Summary

Evofem Biosciences Stock (OTC: EVFM) stock price, news, charts, stock research, profile.

Loading...
Day Range0.047 - 0.05052 Wk Range0.041 - 1.570Open / Close0.048 / 0.048Float / Outstanding121.036M / 121.223M
Vol / Avg.1.725M / 1.976MMkt Cap5.807MP/E-50d Avg. Price0.070
Div / Yield (Forward)- / -%Payout Ratio-Total Float121.036MEPS-6.260
PRNewswire - Oct 3, 2022, 8:30AM
PRNewswire - Sep 16, 2022, 6:00AM
Seeking Alpha - Sep 12, 2022, 11:08AM
Seeking Alpha - Aug 4, 2022, 4:37PM
Seeking Alpha - Jul 13, 2022, 10:57AM
Seeking Alpha - Jul 7, 2022, 1:42PM
Seeking Alpha - Jul 6, 2022, 1:48PM
InvestorPlace - Jun 28, 2022, 4:58PM
Seeking Alpha - May 20, 2022, 6:59AM
Seeking Alpha - May 19, 2022, 6:05PM
Sector: Health Care.Industry: Pharmaceuticals
Evofem Biosciences Inc is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmitted infections (STIs). The company's product, Phexxi (lactic acid, citric acid and potassium bitartrate), is a hormone-free, prescription vaginal gel approved in the United States for the prevention of pregnancy. The company is also evaluating its investigational drug candidate EVO100 vaginal gel for the prevention of urogenital transmission of Chlamydia trachomatis infection (chlamydia) and Neisseria gonorrhoeae infection (gonorrhea) in women.

Earnings

see more
Q1 2023Est.ActualSurprise
EPS
(EXPECTED)2023-05-03
REV
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-03-02
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Evofem Biosciences (EVFM) stock?

A

You can purchase shares of Evofem Biosciences (OTCQB: EVFM) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Evofem Biosciences's (EVFM) competitors?

A

There are no as such competitors for Evofem Biosciences.

Q

What is the target price for Evofem Biosciences (EVFM) stock?

A

The latest price target for Evofem Biosciences (OTCQB: EVFM) was reported by Stifel on Thursday, October 13, 2022. The analyst firm set a price target for 0.50 expecting EVFM to rise to within 12 months (a possible 943.84% upside). 9 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Evofem Biosciences (EVFM)?

A

The stock price for Evofem Biosciences (OTCQB: EVFM) is $0.0479 last updated February 8, 2023 at 8:54 PM UTC.

Q

Does Evofem Biosciences (EVFM) pay a dividend?

A

There are no upcoming dividends for Evofem Biosciences.

Q

When is Evofem Biosciences (OTCQB:EVFM) reporting earnings?

A

Evofem Biosciences’s Q1 earnings are confirmed for Wednesday, May 3, 2023.

Q

Is Evofem Biosciences (EVFM) going to split?

A

There is no upcoming split for Evofem Biosciences.

Q

What sector and industry does Evofem Biosciences (EVFM) operate in?

A

Evofem Biosciences is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCQB.